Dysfunction of alpha- and beta-cells in type 1 diabetes (T1D) and type 2 diabetes (T2D) patients manifests as inappropriate glucagon response [1,2], and during hypoglycaemia glucagon has been identified as a major player during counter-regulation [4]. This evidence concerns the gene GCG and type 2 diabetes mellitus.